Although the overall number (frequency) of Tregs may be unchanged in MS patients compared to controls, studies indicate that their inhibitory function is impaired, which correlates with diminished immune control in vivo ( Further studies have shown the absence of GSH in T cells does not interfere with TCR signaling but leads to a failure to reprogram cellular processes needed for robust clonal expansion and prevents the induction of aerobic glycolysis and the increase in cell size associated with T cell activation (Klein Geltink et al., 2017)
Caponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, Wixner J, Maurer MS, Garcia-Pavia P, Tournev I, et al
Phase 2 trials show an average weight loss of 24% after 48 weeks on the highest dose of 12mg
This dual-compound approach targets multiple metabolic pathways simultaneously, which some patients find more effective than single-agent therapy
Im very impressed by the onboarding, platform, and insights